Study objective-The aims were to determine the relationship between spirometric indices and mortality among lifelong non-smokers, and to investigate whether the association of short stature with increased risk of death is explained by reduced levels of ventilatory function in shorter men.
Associations have been described between reduced ventilatory function and subsequent mortality or non-fatal coronary heart disease. °T hese have generally used statistical modelling to control for smoking habit, but because the influence of smoking upon both ventilatory function and mortality is so strong, such adjustment may be inadequate. In such circumstances, residual confounding by smoking would generate a spurious association between diminished lung function and mortality. A recent analysis of the relationship of ventilatory function to coronary heart disease in Hawaii found no association among non-smokers and suggested that the association observed among smokers was explained by residual confounding."
Other studies, however, suggest that a real association may exist. In Baltimore, all cause mortality during 24 years of follow up was significantly and inversely related to FEV, adjusted for age and height among lifelong nonsmokers.'2 Similar findings have been reported for vital capacity among healthy non-smokers in the Framingham study,13 and the Copenhagen City Heart Study.'4 A longitudinal study in Papua New Guinea found that the local methods of smoking tobacco were not associated with increased risk of death but that reduced ventilatory function was nevertheless an important predictor of all cause mortality. '5 Men of short stature are at increased risk of death and coronary heart disease. ''8 These associations have attracted considerable interest because height, in so far as it is influenced by environmental factors, is mainly determined during childhood and adolescence. A recent analysis of incident cases of myocardial infarcation in the British Regional Heart Study suggested that the effect of height on risk of myocardial infarcation may be explained by the tendency for short men to have lower levels of ventilatory function. ' In order to compare the relative importance of various risk factors as predictors of mortality in the whole group of non-smoking men, the distribution of each risk factor was adjusted for age and standardised to a common scale. This was achieved by calculating the difference between the measurement for each man and the mean of measurements for all lifelong non-smokers of the same single year of age in the study population, and dividing this by the standard deviation of measurements for men of the same age. These age specific "z scores" were then ranked and the upper, middle, and lower thirds of the distribution were used in the analysis. The use of these age adjusted tertiles removed any confounding effect of age upon the relationship between the level of each risk factor and subsequent mortality.
Results

STUDY POPULATION
Among 18 403 men aged 40-64 years at examination, 3455 (19%) denied ever having smoked cigarettes, cigars, or a pipe. Three men (all of whom died during follow up) had no spirometric measurements recorded. Among the remaining 3452 men there were 445 deaths during 60 084 person-years of follow up (average 17 4 years per man). These included 11 deaths from lung cancer.
The entry examinations preceded the adoption of internationally accepted criteria for definition of spirometric indices.23 However, a sample of the original spirograms from lifelong non-smokers was inspected as part of another study. The sum of the FEV1 and FVC from each of the two "best tests", as defined by the American Thoracic Society criteria,23 were within 50% of each other in 84% (73/87) spirograms, within 7% in 91% (79/87), and within 10% in 98% (85/87).
Forced expiratory volume in one second (FEV1) was strongly related to age, height, and employment grade, which together explained 31% of the variance. The effect of employment grade was mainly due to a difference of 300 ml in mean age-height adjusted FEV1 between the 2717 men in "high" grades (administrative, professional, and executive posts) and the 571 in "low" grades (clerical and messenger posts). One hundred and sixty four men in the British Council and Diplomatic Service (excluded from the above grade categories) had similar adjusted FEV1 to those in the "high" grades. After Table I shows the rate ratios (per litre decrease in FEV1) for various causes of death. Reduced levels of FEV1 (adjusted for age and height by matching) were associated with increased mortality for all groups of causes studied. This excess was most marked for respiratory disease, but remained highly significant when nonrespiratory causes were considered. Among the non-respiratory causes, the association with cancer deaths was weakest, and that with noncancer, non-circulatory deaths was strongest. However, this heterogeneity of rate ratios could readily be due to chance (X2 for interaction = 0 71, df= 2). When circulatory deaths were further subdivided, reduced FEV1 was significantly associated with both coronary and non-coronary mortality. Fatal strokes accounted for half of the latter category.
The effect of FEV1 on all cause mortality was examined by age at death and duration of follow up. There was no substantial variation in the rate ratios for death above and below 70 years (X2 for interaction=0 20, df= 1). The association of FEV1 with death in the first 10 years of follow up (rate ratio per litre decrease= 1-94, 95% CI 1 46-2-57) was stronger than with later deaths (1 28, 1 01-1 64) , the interaction being significant (X2 = 4.90, df= 1). Inclusion of prevalent coronary heart disease as an additional covariate reduced the independent effect of FEV1 (table II) but the latter remained significant at the 5°% level (x2 = 3 99, df = 1). The association of FEV1 with circulatory mortality was not confined to those with prevalent coronary heart disease (X2 for interaction = 009, df= 1).
Among those with no prevalent heart disease, the 
Discussion
The restriction of this analysis to lifelong nonsmokers was based upon self reported smoking habit, and it is likely that some misclassification of smokers as non-smokers occured. However, it is unlikely that such errors were common enough to generate an association between ventilatory function and mortality of the magnitude that was observed. It is possible that spirometric performance was influenced by preclinical disease present at examination,24 but the effect of FEV, on mortality was found even after 10 years follow up and also among subjects with no respiratory symptoms.
The observed association between reduced ventilatory function and risk of death in this cohort is therefore more likely to be real than spurious. Follow up was limited to fatal events, so it is not possible to distinguish whether the excess mortality among the men with low levels of FEV1 was due to increased incidence of disease or to greater case fatality. The association of reduced ventilatory function with mortality was not confined to any specific cause of death, and it is likely that no single mechanism accounts for all these relationships.
Early 
